DC 260126
Chemical Name: N-(4-Butylphenyl)-4-fluorobenzenesulfonamide
Purity: ≥98%
Biological Activity
DC 260126 is a free fatty acid receptor 1 (FFA1/GPR40) antagonist. Inhibits FFA-induced increases in intracellular Ca2+ levels and suppresses palmitic acid potentiated glucose-stimulated insulin secretion in Min6 pancreatic β cells in vitro. Decreases serum insulin levels, improves insulin sensitivity and reduces the number of apoptotic pancreatic β cells in obese diabetic (db/db) rats.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
DC260126, a small-molecule antagonist of GPR40, improves Ins tolerance but not glucose tolerance in obese Zucker rats.
Zhang et al.
Biomed.Pharmacother., 2010;64:647 -
A novel class of antagonists for the FFAs receptor GPR40.
Hu et al.
Biochem.Biophys.Res.Comm., 2009;390:557 -
DC260126: a small-molecule antagonist of GPR40 that protects against pancreatic β-Cells dysfunction in db/db mice.
Sun et al.
PLoS ONE, 2013;8:e66744
Product Datasheets
Reconstitution Calculator
Molarity Calculator
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for DC 260126
There are currently no reviews for this product. Be the first to review DC 260126 and earn rewards!
Have you used DC 260126?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image